WHAT IS THE WORLD IMMUNOTHERAPY CONGRESS?

Networking


It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
 

 

FIND OUT MORE

Conference


The World Immunotherapy Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.

 

FIND OUT MORE

Exhibition

Exhibit


This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.

 

FIND OUT MORE


Co-located with

 

World Biosimilar congress

European Antibody Congress

HPAPI World Congress

Part of

 

Festival of Biologics

2018 Speakers include

 

  • Dr Alain Beck at World Immunotherapy Congress
    Dr Alain Beck
    Senior Director, NBEs Analytical Chemistry
    Centre d'Immunologie Pierre Fabre
    Jenny Alltoft at World Immunotherapy Congress
    Jenny Alltoft
    Head of Global Biosimilars
    Pfizer
  • Agnete Fredriksen at World Immunotherapy Congress
    Agnete Fredriksen
    President and Chief Scientific Officer
    Vaccibody As
    Alan K. Smith at World Immunotherapy Congress
    Alan K. Smith
    Executive Vice President, Technical Operations
    Bellicum Pharmaceuticals
  • Martin Schiestl at World Immunotherapy Congress
    Martin Schiestl
    Chief Science Officer
    Sandoz Novartis
    Dr Alexey Rak at World Immunotherapy Congress
    Dr Alexey Rak
    Head of Bio Structure and Biophysics
    Sanofi
  • Andreas Katopodis at World Immunotherapy Congress
    Andreas Katopodis
    CEO
    Anaveon
    Sarfaraz Niazi at World Immunotherapy Congress
    Sarfaraz Niazi
    Chairman, Professor
    Karyo Biologics/UIC
  • Deborah Charych at World Immunotherapy Congress
    Deborah Charych
    Executive Director
    Nektar Therapeutics
    Dr Marjorie Shapiro at World Immunotherapy Congress
    Dr Marjorie Shapiro
    Chief of Laboratory of Molecular and Developmental Immunology
    CDER, FDA
  • Dr David Gilham at World Immunotherapy Congress
    Dr David Gilham
    Vice President of Research and Development
    Celyad
    Anna Tafuri at World Immunotherapy Congress
    Anna Tafuri
    Medical Director, Translational Medicine Oncology
    Bayer HealthCare
  • Emma Lees at World Immunotherapy Congress
    Emma Lees
    Senior Vice President, Research
    Jounce Therapeutics
    Darko Skegro at World Immunotherapy Congress
    Darko Skegro
    Senior Investigator, Biotherapeutic Technologies
    Novartis Institutes for Biomedical Research
  • Delphine Courmier at World Immunotherapy Congress
    Delphine Courmier
    Health Economics Director, Biosimilars
    Amgen Inc
    Dr Frédéric Triebel at World Immunotherapy Congress
    Dr Frédéric Triebel
    Chief Scientific Officer and Medical Officer
    Immutep Ltd
  • James Kent at World Immunotherapy Congress
    James Kent
    Specialist Procurement Pharmacist London & East of England
    NHS England
    Hans-Martin Mueller at World Immunotherapy Congress
    Hans-Martin Mueller
    Director, Biotech Development
    Merck
  • Jonathan Back at World Immunotherapy Congress
    Jonathan Back
    Deputy Director, Project Team Lead, Drug Discovery
    Glenmark Pharmaceuticals SA
    Erin Federman at World Immunotherapy Congress
    Erin Federman
    VP, Head of Biologics
    Boehringer Ingelheim
  • Dr John Delaney at World Immunotherapy Congress
    Dr John Delaney
    Executive Director, Amgen Biologics Discovery
    Amgen
    Ian Henshaw at World Immunotherapy Congress
    Ian Henshaw
    Global Head of Biogen’s Biosimilars Unit
    Biogen
  • Joseph Eid at World Immunotherapy Congress
    Joseph Eid
    Senior Vice President, Head of Global Medical Affairs
    Bristol Myers Squibb
    Lioudmila Tchistiakova at World Immunotherapy Congress
    Lioudmila Tchistiakova
    Senior Director of Global Biotherapeutic Technologies
    Pfizer
  • Dr Marjorie Shapiro at World Immunotherapy Congress
    Dr Marjorie Shapiro
    Chief of Laboratory of Molecular and Developmental Immunology
    CDER, FDA
    Dr Karin Jooss at World Immunotherapy Congress
    Dr Karin Jooss
    Chief Scientific Officer
    Gritstone Oncology
  • Jonathan Underhill at World Immunotherapy Congress
    Jonathan Underhill
    Associate Director for Medicines Evidence
    NICE
    Dr Michael Streit at World Immunotherapy Congress
    Dr Michael Streit
    Sr Director Clinical Research Lead
    Janssen
  • Houng Kim at World Immunotherapy Congress
    Houng Kim
    head of the strategy and operations division
    Celltrion Healthcare
    Lothar Germeroth at World Immunotherapy Congress
    Lothar Germeroth
    Senior Vice President and Managing Director
    Juno Therapeutics
  • Partha Chowdhury at World Immunotherapy Congress
    Partha Chowdhury
    Senior Director and Head, Antibody Discovery
    Sanofi Genzyme
    Clare Jacklin at World Immunotherapy Congress
    Clare Jacklin
    Director
    National Rheumatoid Arthritis Society
  • Dr M. Anthony Moody at World Immunotherapy Congress
    Dr M. Anthony Moody
    Associate Professor of Paediatrics, Assistant Professor of Immunology
    Duke University Medical Center
    Andreas Herrmann at World Immunotherapy Congress
    Andreas Herrmann
    Chief Executive Officer
    Valerius Biopharma
  • Matthew Hewitt at World Immunotherapy Congress
    Matthew Hewitt
    Director, Tumour Immunology & Microenvironment
    Bellicum Pharmaceuticals
    Patrick Burke at World Immunotherapy Congress
    Patrick Burke
    Associate Director
    Seattle Genetics Inc
  • Niklas Engler at World Immunotherapy Congress
    Niklas Engler
    Head of Technical Development Biologics for Europe
    F. Hoffmann-La Roche AG
    Ruediger Jankowsky at World Immunotherapy Congress
    Ruediger Jankowsky
    Managing Director
    Cinfa Biotech
  • Paul Carter at World Immunotherapy Congress
    Paul Carter
    Senior Director and Staff Scientist, Antibody Engineering
    Genentech
    Pascal Touchon at World Immunotherapy Congress
    Pascal Touchon
    Senior Vice President and Global Head Cell & Gene
    Novartis
  • Per Ola Freskgard at World Immunotherapy Congress
    Per Ola Freskgard
    Vice Director & Expert Scientist
    Roche Innovation Center Basel
    Roman Drai at World Immunotherapy Congress
    Roman Drai
    Director, Clinical Development
    Geropharm
  • Divya Chadha Manek at World Immunotherapy Congress
    Divya Chadha Manek
    Head of Business Development (Commercial)
    National Institute for Health Research (NIHR)
    Phil Bland-Ward at World Immunotherapy Congress
    Phil Bland-Ward
    Chief Scientific Officer
    Crescendo Biologics Ltd
  • Roland Kontermann at World Immunotherapy Congress
    Roland Kontermann
    Professor Of Biomedical Engineering
    University of Stuttgart
    Meenu Wadhwa at World Immunotherapy Congress
    Meenu Wadhwa
    Section Leader for Cyotkines and Growth Factors Section
    NIBSC
  • Thomas Nittoli at World Immunotherapy Congress
    Thomas Nittoli
    Director
    Regeneron Pharmaceuticals
    Serafino Pantano at World Immunotherapy Congress
    Serafino Pantano
    Director, Biomarker & Diagnostics Leader
    Merck Sharp & Dohme
  • Dr Shane Olwill at World Immunotherapy Congress
    Dr Shane Olwill
    Vice President of Development
    Pieris Pharmaceuticals
    Jatinder Harchowal at World Immunotherapy Congress
    Jatinder Harchowal
    Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit
    Royal Marsden NHS Foundation Trust
  • Dr William Dall'Acqua at World Immunotherapy Congress
    Dr William Dall'Acqua
    VP, R&D
    MedImmune
    Zhaoyang (Megan) Li at World Immunotherapy Congress
    Zhaoyang (Megan) Li
    Director, Translational Medicine & Clinical Pharmacology
    Sanofi
  • Ingrid Bourges at World Immunotherapy Congress
    Ingrid Bourges
    Clinical Assessor
    Federal Agency for Medicines and Health Products
    Louis Boon at World Immunotherapy Congress
    Louis Boon
    Chief Scientific Officer
    Bioceros

 

SEE MORE SPEAKERS

"Great depth and variety with engaging open discussions across industry/academic and biotech."


Biomarker Development Specialist, Cancer Research U.K. Cambridge Institute

World Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy CongressWorld Immunotherapy Congress

2018 Advisory Board

The agenda is being shaped by an industry advisory board, with members including:

 

Dario Neri, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Dario Neri

Founder, Philogen;
Professor of Chemistry & Applied Biology
Swiss Federal Institute of Technology Zurich

Roy Baynes, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Roy Baynes

SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)

M. Anthony Moody, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre
M. Anthony Moody

Associate Professor, Department of Paediatrics, Division of Infectious Diseases
Duke University Medical Centre

Frédéric Triebel, Chief Scientific Officer, Chief Medical Officer, Prima BioMed
Frédéric Triebel

Chief Scientific Officer, Chief Medical Officer
Prima BioMed

Shane Olwill, Head of Immuno-Oncology, Pieris Pharmaceuticals
Shane Olwill

Head of Immuno-Oncology
Pieris Pharmaceuticals

Alain Vertes, Managing Director, NxR Biotechnologies
Alain Vertes

Managing Director
NxR Biotechnologies

Ahuva Nissim, Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University
Ahuva Nissim

Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology
William Harvey Research Institute, Queen Mary University

 

Joern Schmitz, Head, Department of Immunotherapy, Fraunhofer IME
Joern Schmitz

Head, Department of Immunotherapy
Fraunhofer IME

Who Attends

 

AbbVie     Abzena     ADC Therapeutics     Alligator Bioscience     Amgen     AstraZeneca     Biogen     Biosim Spanish Association of Biosimilars     Boehringer Ingelheim     Bristol Myers Squibb     Cancer Research UK     Cinfa Biotech GmbH     Dr. Reddy's Laboratories SA.     Duke University Medical Centre     Eli Lilly & Co     European Molecular Biology Laboratory     European Patent Office     European Specialist Nurses Organisations     Ferrer International     Fraunhofer IME     Gedeon Richter     Goldstein & Fox     GSK     HPAPI Project Services Ltd     Janssen     Libbs Pharmaceutica     Lonza     mAbs     Macrogenics     Maverick Therapeutics     MedImmune     Merck     Merck, Sharp & Dohme (MSD)     Napp pharmaceuticals     NAPP Pharmaceuticals     NBE Therapeutics     NHS     NIBR     NICE     NIHR Clinical Research Network (NIHR CRN)     Norwegian Medicines Agency     Novartis     NovImmune     NxR Biotechnologies     Opsona Therapeutics     Oril Industrie     Ossianix     PAREXEL     Paul Ehrlich Institute     Pfizer Biotherapeutics     Pieris Pharmaceuticals     Pierre Fabre     Prima BioMed     Roche     Roche     S.A.Toral      SafeBridge       Sandoz Biopharmaceuticals     Sandoz      Sanofi     Sanofi R&D     Sanquin     Seattle Genetics     Technische Universität Braunschweig     Teva Pharmaceuticals     The Royal Marsden NHS Foundation Trust     Therapeomic     TU Wien     UCB Celltech     University of Cambridge     University of Denmark      University of Messina – Italy     University of Stuttgart

 

FIND OUT MORE

Sponsors & Exhibitors

 

  • Partner

    Canton of Basel-Stadt at World Immunotherapy Congress

    Silver Sponsor

    Abcam at World Immunotherapy Congress

    Gold Sponsor

    KBI Biopharma at World Immunotherapy Congress
  • Gold Sponsor

    Fujifilm Diosynth Biotechnologies at World Immunotherapy Congress

    Gold Sponsor

    MabDesign at World Immunotherapy Congress

    Silver Sponsor

    ACRO Biosystems Inc at World Immunotherapy Congress
  • Silver Sponsor

    Icosagen Cell Factory OU at World Immunotherapy Congress

    Silver Sponsor

    Isogenica Ltd at World Immunotherapy Congress

    Silver Sponsor

    MaxCyte at World Immunotherapy Congress
  • Silver Sponsor

    Sartorius Corporate Administration GmbH at World Immunotherapy Congress

    Silver Sponsor

    Schrödinger at World Immunotherapy Congress

    Associate Sponsor

    AbCheck at World Immunotherapy Congress
  • Associate Sponsor

    Abzena at World Immunotherapy Congress

    Associate Sponsor

    Axinn at World Immunotherapy Congress

    Associate Sponsor

    Bioreclamationivt at World Immunotherapy Congress
  • Associate Sponsor

    Dynamic Biosensors at World Immunotherapy Congress

    Associate Sponsor

    Food Pharma Systems at World Immunotherapy Congress

    Associate Sponsor

    Immatics Biotechnologies GmbH at World Immunotherapy Congress
  • Associate Sponsor

    Infors at World Immunotherapy Congress

    Associate Sponsor

    Lonza at World Immunotherapy Congress

    Associate Sponsor

    Pepscan Presto BV at World Immunotherapy Congress
  • Associate Sponsor

    Sterne Kessler Goldstein And Fox Plc at World Immunotherapy Congress

    Exhibitor

    Bachem at World Immunotherapy Congress

    Exhibitor

    Biotem Custom Antibodies and Services at World Immunotherapy Congress
  • Exhibitor

    Creoptix AG at World Immunotherapy Congress

    Exhibitor

    T.E.C.O. Medical Ag at World Immunotherapy Congress

    Exhibitor

    Adolf Kuhner Ag at World Immunotherapy Congress
  • Exhibitor

    Aldevron at World Immunotherapy Congress

    Exhibitor

    Anaquant Biologics and Biomarkers Analyses at World Immunotherapy Congress

    Exhibitor

    Axenis at World Immunotherapy Congress
  • Exhibitor

    BioRad at World Immunotherapy Congress

    Exhibitor

    Bio-Techne at World Immunotherapy Congress

    Exhibitor

    CitoxLab Atlanbio at World Immunotherapy Congress
  • Exhibitor

    DiscoverX Corporation Ltd at World Immunotherapy Congress

    Exhibitor

    EasyChelators SAS at World Immunotherapy Congress

    Exhibitor

    Envigo at World Immunotherapy Congress
  • Exhibitor

    Evidentic GmbH at World Immunotherapy Congress

    Exhibitor

    Groupe NOVASEP at World Immunotherapy Congress

    Exhibitor

    I and L Biosystems at World Immunotherapy Congress
  • Exhibitor

    imAb at World Immunotherapy Congress

    Exhibitor

    MAbSilico at World Immunotherapy Congress

    Exhibitor

    MI-mAbs at World Immunotherapy Congress
  • Exhibitor

    MInakem High Potent at World Immunotherapy Congress

    Exhibitor

    MP Biomedicals at World Immunotherapy Congress

    Exhibitor

    MUNIT at World Immunotherapy Congress
  • Exhibitor

    NIHR Clinical Research Network at World Immunotherapy Congress

    Exhibitor

    Quality Assistance S.A. at World Immunotherapy Congress

    Exhibitor

    PX Therapeutics at World Immunotherapy Congress
  • Exhibitor

    Proteo Genix at World Immunotherapy Congress

    Exhibitor

    R.D. Biotech at World Immunotherapy Congress

 

SPONSORSHIP OPPORTUNITIES


Put your company at the forefront of the immunotherapy community and sponsor the World Immunotherapy Congress.

Download the prospectus to see how you can get involved.

 

DOWNLOAD PROSPECTUS

See you in Basel  |  29th - 31st October

 

 

REGISTER NOW

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates